Bremer Bank National Association’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,934
Closed -$255K 194
2022
Q2
$255K Sell
1,934
-188
-9% -$24.7K 0.05% 189
2022
Q1
$282K Sell
2,122
-313
-13% -$37.5K 0.05% 190
2021
Q4
$283K Sell
2,435
-57
-2% -$6.71K 0.05% 191
2021
Q3
$299K Buy
+2,492
New +$290K 0.06% 165
2020
Q4
Sell
-1,832
Closed -$200K 198
2020
Q3
$200K Buy
+1,832
New +$204K 0.05% 191
2019
Q2
Sell
-2,004
Closed -$151K 275
2019
Q1
$151K Buy
+2,004
New +$158K 0.03% 283

Other funds holding AZN

Bremer Bank National Association's AZN Position: Q3 2022 in Review

Bremer Bank National Association sold out of AstraZeneca (AZN) in Q3 2022, closing a stake of 1,934 shares — an estimated $255K sold.

Bremer Bank National Association first reported a position in AZN in Q1 2019 and held it in 6 quarters. The position peaked at $299K in Q3 2021. 966 funds tracked by Wall St. Rank hold AZN as of Q3 2022.

  • Bremer Bank National Association reported no remaining AstraZeneca position as of Q3 2022 after selling out during the quarter.
  • Bremer Bank National Association sold 1,934 AstraZeneca shares in Q3 2022, an estimated $255K.
  • Bremer Bank National Association first reported a position in AstraZeneca in Q1 2019 and held it in 6 quarters.
  • Bremer Bank National Association's AstraZeneca position peaked at $299K in Q3 2021.
  • 966 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2022.

Based on Bremer Bank National Association's 13F filing for Q3 2022, filed 12 Oct 2022.